Mania Clinical Trial
Official title:
A Pilot Randomised Controlled Trial of Cognitive Behaviour Therapy for Early Bipolar Disorder
There is a need to develop a better understanding of the early phase of bipolar disorder, and to develop and evaluate effective psychosocial interventions that assist people in this phase. The purpose of this study is to determine whether or not it is feasible to conduct a larger study of the effectiveness of cognitive interpersonal therapy (a psychological therapy) with individuals who have experienced their first or second treated episode of mania or hypomania (symptoms common in early development of bipolar disorders).
The 'PICO' framework (Oxman, Sackett, and Guyatt, 1993; Richardson, Wilson, Nishikawa, and
Hayward; 1995) was used to specify the parameters of the study aims and objectives:
1. Population: could appropriate individuals be identified and recruited to a trial of CIT
for early bipolar disorder?
2. Intervention: would CIT be an acceptable intervention for individuals following a first
or second treated episode of mania and or hypomania? Could we identify any
modifications required to the CIT protocol used with this group?
3. Control group: could an appropriate group of participants be recruited to facilitate a
comparison with the CIT intervention? Could we explicitly establish the usual care
package and its local implementation?
4. Outcomes: which outcomes are appropriate for measuring relevant dimensions of a
treatment effect?
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT00534222 -
Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect
|
N/A | |
Completed |
NCT00140179 -
Valnoctamide in Mania
|
Phase 3 | |
Completed |
NCT01237379 -
Peroxisomal Defects and Familial Risk for Bipolar Disorder
|
N/A | |
Completed |
NCT00254488 -
Treatment of Bipolar Mania in Older Adults
|
Phase 4 | |
Completed |
NCT00560079 -
Efficacy of Allopurinol and Dypiridamole in Acute Mania
|
Phase 4 | |
Completed |
NCT00518947 -
Pharmacotherapy of Treatment-Resistant Mania
|
Phase 3 | |
Recruiting |
NCT05444907 -
Deep Brain Stimulation-Induced Mania in Parkinson's Disease
|
||
Enrolling by invitation |
NCT02360267 -
Pediatric Bipolar Registry
|
||
Completed |
NCT01092221 -
Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
|
Phase 3 | |
Completed |
NCT00521365 -
Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
|
Phase 4 | |
Completed |
NCT01191918 -
The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania
|
Phase 4 | |
Completed |
NCT01541605 -
Methylphenidate for the Treatment of Acute Mania
|
Phase 3 | |
Completed |
NCT00893581 -
Multimodal Neuroimaging of Treatment Effects in Adolescent Mania
|
N/A | |
Completed |
NCT00208195 -
Depakote ER Therapy for Mania Comorbid With Substance Abuse
|
Phase 4 | |
Completed |
NCT00181922 -
Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
|
Phase 4 | |
Completed |
NCT00181935 -
Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
|
Phase 4 | |
Active, not recruiting |
NCT05703711 -
Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa
|
N/A | |
Completed |
NCT00917501 -
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
|
Phase 2 | |
Completed |
NCT00334347 -
A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR
|
Phase 4 |